ArticleDiabetology & metabolic syndrome2026

Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin-niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectives.

Yi Tseng Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.